Indo National invests ₹74.90 lakh in Medcuore, holds 60.34%

1 min read     Updated on 13 Jul 2026, 06:34 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Indo National invested ₹74,90,808 in Medcuore Medical Solutions, acquiring an additional 1.18% stake and increasing its total holding to 60.34%. The transaction, valued at ₹16,536 per share for 453 shares, aims to drive business growth and revenue. MMSPL, which manufactures air monitoring systems and purifiers, recorded a turnover of ₹1,45,60,000 in FY 26.

powered bylight_fuzz_icon
45493449

*this image is generated using AI for illustrative purposes only.

Indo National has invested an aggregate amount of ₹74,90,808 in Medcuore Medical Solutions Private Ltd (MMSPL) by subscribing to equity shares. The investment represents an additional 1.18% of the paid-up share capital in MMSPL on a fully diluted basis. Following this acquisition, Indo National's aggregate shareholding in MMSPL now stands at 60.34%. The transaction was completed via cash consideration based on a valuation report issued by a registered valuer.

The acquisition is not classified as a related party transaction, and none of the promoter, promoter group, or group companies have any interest in the entity being acquired. MMSPL is engaged in the business of manufacturing, distribution, and providing services related to Air Monitoring Systems and Air Purifiers. The object of the acquisition is to facilitate business growth, generate revenue, and earn profit through business expansion. No governmental or regulatory approvals were required for the transaction, which is expected to be completed up to FY 2027-28.

Financial Details of Medcuore Medical Solutions

MMSPL reported a turnover of ₹1,45,60,000 for FY 26. The entity was incorporated on June 7, 2020, and operates within India. The price per share for the acquisition was ₹16,536, with a total of 453 shares acquired.

Period Turnover
FY 26 ₹1,45,60,000
FY 25 ₹35,41,484
FY24 ₹47,68,000

The disclosure was made pursuant to Regulation 30 of the SEBI LODR Regulations and the SEBI master circular dated November 11, 2024.

Historical Stock Returns for Indo National

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-1.48%-7.06%-14.44%-27.24%-39.29%

What strategic synergies does Indo National expect to leverage by increasing its stake to over 60% in the air monitoring solutions sector?

How will the significant surge in MMSPL's turnover from FY25 to FY26 impact the consolidated revenue of Indo National in the coming fiscal years?

Does Indo National plan to provide further financial support or capital infusion to MMSPL to sustain its recent rapid growth trajectory?

Indo National invests ₹99.88 lakh in Medcuore, raises stake to 59.16%

1 min read     Updated on 31 May 2026, 05:00 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Indo National Limited invested ₹99,87,744 in Medcuore Medical Solutions Private Ltd to acquire an additional 1.68% equity stake, increasing its total holding to 59.16%. The company purchased 604 shares at ₹16,536 per share via cash consideration. Medcuore, which manufactures Air Monitoring Systems and Air Purifiers, reported a turnover of ₹1,45,60,000 for FY 25-26.

powered bylight_fuzz_icon
41680111

*this image is generated using AI for illustrative purposes only.

Indo National Limited has invested an aggregate amount of ₹99,87,744 in Medcuore Medical Solutions Private Ltd (MMSPL) to acquire an additional 1.68% equity stake. This strategic investment increases Indo National 's aggregate shareholding in MMSPL to 59.16% on a fully diluted basis. The transaction was completed via a cash consideration based on a valuation report issued by a registered valuer.

The company acquired 604 shares at a price of ₹16,536 per share. MMSPL is engaged in the business of manufacturing, distribution, and providing services related to Air Monitoring Systems and Air Purifiers. The acquisition is not classified as a related party transaction, and no promoters or group companies hold any interest in the entity being acquired.

The primary object of this acquisition is to facilitate business growth, generate revenue, and earn profit through expansion. The target entity reported a turnover of ₹1,45,60,000 for FY 25-26. The indicative time period for the completion of this acquisition is up to FY 2027-28.

Financial Overview of Medcuore Medical Solutions

The following table details the turnover of MMSPL over the last three financial years:

Period Turnover
FY 26 ₹1,45,60,000
FY 25 ₹35,41,484
FY24 ₹47,68,000

The investment was intimated to the exchanges under Regulation 30 of the SEBI LODR Regulations. J. Srinivasan, Company Secretary, confirmed the disclosure on May 30, 2026.

Historical Stock Returns for Indo National

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-1.48%-7.06%-14.44%-27.24%-39.29%

What specific expansion strategies does Indo National plan to implement to capitalize on MMSPL's 311% year-over-year revenue growth?

How will Indo National fund the remaining investment required to reach the indicative completion period of FY 2027-28?

Does the increased stake to 59.16% signal an intent to launch a full takeover bid or merge MMSPL in the future?

More News on Indo National

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-27.24%